1 |
BERTUCCI F,FINETTI P,ROCHE H,et al.Comparison of the prognostic value of genomic grade index,Ki67 expression and mitotic activity index in early node-positive breast cancer patients[J]. Ann Oncol,2013,24(3):625-632.
|
2 |
苏静,郑杰. 肿瘤增殖标记分子Ki-67和增殖细胞核抗原及其在病理诊断中的应用[J]. 中华病理学杂志,2009,38(8):568-571.
|
3 |
NILSSON C,KOLIADI A,JOHANSSON I,et al.High proliferation is associated with inferior outcome in male breast cancer patients[J].Mod Pathol,2013,26(1):87-94.
|
4 |
JIANG XH,SUN JW,XU M,et al.Frequent hyperphosphorylation of AS160 in breast cancer[J]. Cancer Biol Ther,2010,10(4):362-367.
|
5 |
姜小华,李君,孙建文,等.原发性乳腺癌p-AS160(Thr642)水平与常用临床病理指标的相关性研究[J]. 中华乳腺病杂志:电子版,2012,6(3):298-303.
|
6 |
TAVASSOLI FA,DEVILEE P.World Health Organization classification of tumours.Pathology and genetics of tumours of the breast and female genital organs[M]. Lyon:IARC Press,2003:10.
|
7 |
JALAVA P,KUOPIO T,JUNTTI-PATINEN L,et al.Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index[J]. Histopathology,2006,48(6):674-682.
|
8 |
SAKAMOTO K,HOLMAN GD.Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic[J]. Am J Physiol Endocrinol Metab,2008,295(1): E29-E37.
|
9 |
LIU J,ZHANG JF,LU JZ,et al.Astragalus polysaccharide stimulates glucose uptake in L6 myotubes through AMPK activation and AS160/TBC1D4 phosphorylation[J].Acta Pharmacol Sin, 2013,34(1): 137-145.
|
10 |
BARTLETT JM.Biomarkers and patient selection for PI3K/Akt/mTOR targeted therapies:current status and future directions[J]. Clin Breast Cancer,2010,10(Suppl 3):S86-S95.
|
11 |
SALH B,MAROTTA A,WAGEY R,et al.Dysregulation of phosphatidylinositol 3-kinase and downstream effectors in human breast cancer[J]. Int J Cancer,2002,98(1):148-154.
|
12 |
GULLICK WJ,SRINIVASAN R.The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer[J]. Breast Cancer Res Treat,1998,52(1-3):43-53.
|